Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders

British Journal of Haematology

Volumn 138, Issue 2, 2007, Pages 202-212

  Sebti, Yasmine ^a   Le Maux, Amélie ^a   Gros, Frédéric ^a   De Guibert, Sophie ^b   Pangault, Céline ^a   Rouas Freiss, Nathalie ^c   Bernard, Marc ^b   Amiot, Laurence ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b RENNES UNIVERSITY HOSPITAL   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Chronic lymphocytic leukaemia; Immunosuppression; Lymphoproliferative disorders; Non Hodgkin lymphoma; Soluble human leucocyte antigen G

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 2; LEUKOCYTE ANTIGEN; SOLUBLE HUMAN LEUKOCYTE ANTIGEN G; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CELL CULTURE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T CELL LYMPHOMA;

B-LYMPHOCYTES; CELL DIVISION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INTERFERON TYPE II; INTERLEUKINS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; LYMPHOPROLIFERATIVE DISORDERS; MONOCYTES; PROSPECTIVE STUDIES; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 34250862249     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06647.x     Document Type: Article

References (50)

1. Amiot, L., Onno, M., Drenou, B., le Marchand, B., Lamy, T., Semana, G. Fauchet, R. (1996a) Distribution of HLA-G alternative mRNAs including soluble forms in normal lymphocytes and in lymphoid cell-derived leukemia. European Journal of Immunogenetics, 23, 311 320.
2. Amiot, L., Onno, M., Renard, I., Drenou, B., Guillaudeux, T., Le Bouteiller, P. Fauchet, R. (1996b) HLA-G transcription studies during the different stages of normal and malignant hematopoiesis. Tissue Antigens, 48, 609 614.
3. Amiot, L., Onno, M., Drenou, B., Monvoisin, C. Fauchet, R. (1998) HLA-G class I gene expression in normal and malignant hematopoietic cells. Human Immunology, 59, 524 528.
4. Amiot, L., Le Friec, G., Sebti, Y., Drenou, B., Pangault, C., Guilloux, V., Leleu, X., Bernard, M., Facon, T. Fauchet, R. (2003) HLA-G and lymphoproliferative disorders. Seminar in Cancer Biology, 13, 379 385.
5. Bainbridge, D.R., Ellis, S.A. Sargent, I.L. (2000) HLA-G suppresses proliferation of CD4(+) T-lymphocytes. Journal of Reproductive Immunology, 48, 17 26.
6. Blaschitz, A., Juch, H., Volz, A., Hutter, H., Daxboeck, C., Desoye, G. Dohr, G. (2005) The soluble pool of HLA-G produced by human trophoblasts does not include detectable levels of the intron 4-containing HLA-G5 and HLA-G6 isoforms. Molecular Human Reproduction, 11, 699 710.
7. Crisa, L., McMaster, M.T., Ishii, J.K., Fisher, S.J. Salomon, D.R. (1997) Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. Journal of Experimental Medicine, 186, 289 298.
8. Echchakir, H., Bagot, M., Dorothee, G., Martinvalet, D., Le Gouvello, S., Boumsell, L., Chouaib, S., Bensussan, A. Mami-Chouaib, F. (2000) Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis. Journal of Investigative Dermatology, 115, 74 80.
9. el-Far, M., Fouda, M., Yahya, R. el-Baz, H. (2004) Serum IL-10 and IL-6 levels at diagnosis as independent predictors of outcome in non-Hodgkin's lymphoma. Journal of Physiology and Biochemistry, 60, 253 258.
10. Fainardi, E., Rizzo, R., Melchiorri, L., Vaghi, L., Castellazzi, M., Marzola, A., Govoni, V., Paolino, E., Tola, M.R., Granieri, E. Baricordi, O.R. (2003) Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings. Journal of Neuroimmunology, 142, 149 158.
11. Farinha, P., Masoudi, H., Skinnider, B.F., Shumansky, K., Spinelli, J.J., Gill, K., Klasa, R., Voss, N., Connors, J.M. Gascoyne, R.D. (2005) Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood, 106, 2169 2174.
12. Fournel, S., Aguerre-Girr, M., Huc, X., Lenfant, F., Alam, A., Toubert, A., Bensussan, A. Le Bouteiller, P. (2000) Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. Journal of Immunology, 164, 6100 6104.
13. Fujii, T., Ishitani, A. Geraghty, D.E. (1994) A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. Journal of Immunology, 153, 5516 5524.
14. Gros, F., Sebti, Y., de Guibert, S., Branger, B., Bernard, M., Fauchet, R. Amiot, L. (2006) Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages. Neoplasia, 8, 223 230.
15. Ibrahim, E.C., Guerra, N., Lacombe, M.J., Angevin, E., Chouaib, S., Carosella, E.D., Caignard, A. Paul, P. (2001) Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma. Cancer Research, 61, 6838 6845.
16. Ishitani, A. Geraghty, D.E. (1992) Alternative splicing of HLA-G transcripts yields proteinswith primary structures resembling both class I and class II antigens. Proceedings of the National Academy of Sciences of the United States of America, 89, 3947 3951.
17. Karadimitris, A., Patterson, S. Spanoudakis, E. (2006) Natural killer T cells and haemopoiesis. British Journal of Haematology, 134, 263 272.
18. Kirszenbaum, M., Djoulah, S., Hors, J., Prost, S., Dausset, J. Carosella, E.D. (1999) Polymorphism of HLA-G gene and protein. Journal of Reproductive Immunology, 43, 105 109.
19. Kovats, S., Main, E.K., Librach, C., Stubblebine, M., Fisher, S.J. DeMars, R. (1990) A class I antigen, HLA-G, expressed in human trophoblasts. Science, 248, 220 223.
20. Le Friec, G., Laupeze, B., Fardel, O., Sebti, Y., Pangault, C., Guilloux, V., Beauplet, A., Fauchet, R. Amiot, L. (2003) Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Human Immunology, 64, 752 761.
21. Le Friec, G., Gros, F., Sebti, Y., Guilloux, V., Pangault, C., Fauchet, R. Amiot, L. (2004) Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules. Journal of Leukocyte Biology, 76, 1125 1133.
22. Le Rond, S., Azema, C., Krawice-Radanne, I., Durrbach, A., Guettier, C., Carosella, E.D. Rouas-Freiss, N. (2006) Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells. Journal of Immunology, 176, 3266 3276.
23. Lefebvre, S., Antoine, M., Uzan, S., McMaster, M., Dausset, J., Carosella, E.D. Paul, P. (2002) Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. Journal of Pathology, 196, 266 274.
24. Lila, N., Rouas-Freiss, N., Dausset, J., Carpentier, A. Carosella, E.D. (2001) Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proceedings of the National Academy of Sciences of the United States of America, 98, 12150 12155.
25. Lozano, J.M., Gonzalez, R., Kindelan, J.M., Rouas-Freiss, N., Caballos, R., Dausset, J., Carosella, E.D. Pena, J. (2002) Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. Aids, 16, 347 351.
26. Malmberg, K.J., Levitsky, V., Norell, H., de Matos, C.T., Carlsten, M., Schedvins, K., Rabbani, H., Moretta, A., Soderstrom, K., Levitskaya, J. Kiessling, R. (2002) IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. Journal of Clinical Investigation, 110, 1515 1523.
27. Marchal-Bras-Goncalves, R., Rouas-Freiss, N., Connan, F., Choppin, J., Dausset, J., Carosella, E.D., Kirszenbaum, M. Guillet, J. (2001) A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant Proceeding, 33, 2355 2359.
28. McIntire, R.H., Morales, P.J., Petroff, M.G., Colonna, M. Hunt, J.S. (2004) Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-beta1. Journal of Leukocyte Biology, 76, 1220 1228.
29. Moreau, P., Adrian-Cabestre, F., Menier, C., Guiard, V., Gourand, L., Dausset, J., Carosella, E.D. Paul, P. (1999) IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. International Immunology, 11, 803 811.
30. Nakamura, K., Kitani, A., Fuss, I., Pedersen, A., Harada, N., Nawata, H. Strober, W. (2004) TGF-beta 1 plays an important role in the mechanism of CD4 + CD25+ regulatory T cell activity in both humans and mice. Journal of Immunology, 172, 834 842.
31. Nuckel, H., Rebmann, V., Durig, J., Duhrsen, U. Grosse-Wilde, H. (2005) HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood, 105, 1694 1698.
32. Pangault, C., Le Friec, G., Caulet-Maugendre, S., Lena, H., Amiot, L., Guilloux, V., Onno, M. Fauchet, R. (2002) Lung macrophages and dendritic cells express HLA-G molecules in pulmonary diseases. Human Immunology, 63, 83 90.
33. Park, G.M., Lee, S., Park, B., Kim, E., Shin, J., Cho, K. Ahn, K. (2004) Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochemical and Biophysical Research Communications, 313, 606 611.
34. Paul, P., Rouas-Freiss, N., Khalil-Daher, I., Moreau, P., Riteau, B., Le Gal, F.A., Avril, M.F., Dausset, J., Guillet, J.G. Carosella, E.D. (1998) HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proceedings of the National Academy of Sciences of the United States of America, 95, 4510 4515.
35. Paul, P., Adrian Cabestre, F., Ibrahim, E.C., Lefebvre, S., Khalil-Daher, I., Vazeux, G., Moya Quiles, R.M., Bermond, F., Dausset, J. Carosella, E.D. (2000) Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells [In Process Citation]. Human Immunology, 61, 1138 1149.
36. Rebmann, V., Pfeiffer, K., Passler, M., Ferrone, S., Maier, S., Weiss, E. Grosse-Wilde, H. (1999) Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens, 53, 14 22.
37. Rebmann, V., Lemaoult, J., Rouas-Freiss, N., Carosella, E.D. Grosse-Wilde, H. (2005) Report of the wet workshop for quantification of soluble HLA-G in Essen, 2004. Human Immunology, 66, 853 863.
38. Riteau, B., Menier, C., Khalil-Daher, I., Sedlik, C., Dausset, J., Rouas-Freiss, N. Carosella, E.D. (1999) HLA-G inhibits the allogeneic proliferative response. Journal of Reproductive Immunology, 43, 203 211.
39. Sakata, K., Satoh, M., Someya, M., Asanuma, H., Nagakura, H., Oouchi, A., Nakata, K., Kogawa, K., Koito, K., Hareyama, M. Himi, T. (2004) Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma. Cancer, 100, 356 365.
40. Sargent, I.L. (2005) Does 'soluble' HLA-G really exist? Another twist to the tale. Molecular Human Reproduction, 11, 695 698.
41. Sebti, Y., Le Friec, G., Pangault, C., Gros, F., Drenou, B., Guilloux, V., Bernard, M., Lamy, T., Fauchet, R. Amiot, L. (2003) Soluble HLA-G molecules are increased in lymphoproliferative disorders. Human Immunology, 64, 1093 1101.
42. Shiroishi, M., Tsumoto, K., Amano, K., Shirakihara, Y., Colonna, M., Braud, V.M., Allan, D.S., Makadzange, A., Rowland-Jones, S., Willcox, B., Jones, E.Y., van der Merwe, P.A., Kumagai, I. Maenaka, K. (2003) Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proceedings of the National Academy of Sciences of the United States of America, 100, 8856 8861.
43. Singer, G., Rebmann, V., Chen, Y.C., Liu, H.T., Ali, S.Z., Reinsberg, J., McMaster, M.T., Pfeiffer, K., Chan, D.W., Wardelmann, E., Grosse-Wilde, H., Cheng, C.C., Kurman, R.J. Shih Ie, M. (2003) HLA-G is a potential tumor marker in malignant ascites. Clinical Cancer Research, 9, 4460 4464.
44. Ugurel, S., Rebmann, V., Ferrone, S., Tilgen, W., Grosse-Wilde, H. Reinhold, U. (2001) Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer, 92, 369 376.
45. Urosevic, M., Kurrer, M.O., Kamarashev, J., Mueller, B., Weder, W., Burg, G., Stahel, R.A., Dummer, R. Trojan, A. (2001) Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. American Journal of Pathology, 159, 817 824.
46. Urosevic, M., Willers, J., Mueller, B., Kempf, W., Burg, G. Dummer, R. (2002) HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood, 99, 609 617.
47. de Visser, K.E. Kast, W.M. (1999) Effects of TGF-beta on the immune system: implications for cancer immunotherapy. Leukemia, 13, 1188 1199.
48. Wiendl, H., Behrens, L., Maier, S., Johnson, M.A., Weiss, E.H. Hohlfeld, R. (2000) Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G. Annals of Neurology, 48, 679 684.
49. Wiendl, H., Mitsdoerffer, M., Hofmeister, V., Wischhusen, J., Bornemann, A., Meyermann, R., Weiss, E.H., Melms, A. Weller, M. (2002) A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. Journal of Immunology, 168, 4772 4780.
50. Wiendl, H., Mitsdoerffer, M., Hofmeister, V., Wischhusen, J., Weiss, E.H., Dichgans, J., Lochmuller, H., Hohlfeld, R., Melms, A. Weller, M. (2003) The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy. Brain, 126, 176 185.